Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01092650 · ClinicalTrials.gov registry record · Phase 1
Determining Levels of [D10] Phenanthrene Tetraol in Smokers' Urine
A Phase 1 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT01092650 is a Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 30 participants.
The verdict
NCT01092650, a Phase 1 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this research study is to better understand how people respond to cancer-causing chemicals in cigarette smoke. Some people are able to get rid of these chemicals as harmless agents while others suffer damage to their cells that can ultimately result in cancer. We hope to develop a better understanding of how we can identify the people who are in danger of getting cancer. Participants will complete questionnaires regarding their health and smoking history. We will take blood samples to look at genes which determine how the body breaks down some tobacco-related toxins. Participants will be given a small amount of liquid to drink, containing alcohol, water, and a compound called deuterated phenanthrene (DP), which is found in cigarette smoke and in the environment. Phenanthrene is non-toxic and does not cause cancer, but this compound is broken down by the body in the same way as cancer-causing agents. We will follow the pathway of this compound as it is broken down in the body.
Interventions
- DRUG Deuterated phenanthrene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-09 |
| Est. Completion | 2011-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01092650
The ClinicalTrials.gov registry entry for NCT01092650 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Deuterated phenanthrene is the first listed.
NCT01092650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01092650 about?
NCT01092650 is a clinical study titled "Determining Levels of [D10] Phenanthrene Tetraol in Smokers' Urine". The purpose of this research study is to better understand how people respond to cancer-causing chemicals in cigarette smoke. Some people are able to get rid of these chemicals as harmless agents while others suffer damage to their cells that can ultimately result in cancer. We hope to develop a bet...
What is the current status of trial NCT01092650?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2007-09. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01092650?
The interventions under investigation include: Deuterated phenanthrene (DRUG).
Who is sponsoring clinical trial NCT01092650?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.